In ₹ Crore except Per Share Latest Annual	MAXHEALTH FY26	APOLLOHOSP FY26	FORTIS FY26	MEDANTA FY26	Peer Average
Valuation — at last close
P/E	57.39×	60.72×	◆ 54.70×	62.76×	59.39× -3%
P/B	7.71×	12.44×	◆ 5.76×	8.82×	9.00× -14%
EV/EBITDA	38.17×	32.35×	◆ 28.57×	38.09×	33.00× +16%
Market Cap	₹82,828 Cr	₹1.18L Cr	₹56,992 Cr	₹34,922 Cr	₹69,943 Cr +18%
Growth
Revenue CAGR 3Y	◆ 22.43%	14.94%	13.17%	17.85%	15.32% +46%
Revenue CAGR 5Y	◆ 27.30%	19.03%	17.76%	—	18.40% +48%
Net Income CAGR 3Y	9.34%	◆ 33.35%	18.91%	19.33%	23.86% -61%
Revenue YoY (latest Q)	16.70%	20.56%	17.46%	◆ 26.50%	21.51% -22%
Net Income YoY (latest Q)	4.87%	◆ 38.41%	2.26%	-1.09%	13.19% -63%
Profitability
EBITDA Margin	◆ 26.79%	14.94%	22.84%	20.84%	19.54% +37%
Net Income Margin	◆ 17.23%	7.94%	11.66%	12.56%	10.72% +61%
Return on Common Equity	14.33%	◆ 21.95%	11.08%	15.15%	16.06% -11%
Return on Capital Employed	12.63%	◆ 18.20%	12.62%	14.78%	15.20% -17%
Return on Assets	8.89%	9.35%	7.18%	◆ 10.38%	8.97% -1%
Credit & Quality
Total Debt/Equity	0.32×	0.57×	◆ 0.28×	0.30×	0.38× -17%
Interest Coverage	7.64×	6.44×	5.20×	◆ 8.80×	6.81× +12%
Scale — latest FY
Revenue / Total Income	₹8,373 Cr	₹25,229 Cr	₹9,128 Cr	₹4,410 Cr	₹12,922 Cr -35%
Net Income	₹1,442 Cr	₹2,003 Cr	₹1,064 Cr	₹554 Cr	₹1,207 Cr +20%
Total Assets	₹17,231 Cr	₹22,197 Cr	₹15,966 Cr	₹5,905 Cr	₹14,689 Cr +17%
EPS	₹14.83	₹135.04	₹13.8	₹20.71	₹56.52 -74%
Book Value per Share	₹110.43	₹659.26	₹131.07	₹147.44	₹312.59 -65%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.